MatsukiyoCocokara & Co. (MSMKF)
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
MatsukiyoCocokara & Co. (MSMKF) trades at $14.60 with AI Score 49/100 (Grade C). MatsukiyoCocokara & Co. is a leading drug store and pharmacy chain in Japan, operating 1,726 stores across the country. Market cap: $5.74B, Sector: Healthcare.
Price live · AI analysis from Jun 14, 2026Analyst Coverage for MSMKF: MSMKF does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates MSMKF against Healthcare peers across nine fundamental dimensions and assigns an underweight signal based on the underlying data.
MSMKF: the 1 perspectives are evenly split.
How is this calculated? →MatsukiyoCocokara & Co. (MSMKF) Healthcare & Pipeline Overview
MatsukiyoCocokara & Co. stands out in Japan's healthcare sector with its extensive network of drug stores and pharmacies, delivering a diverse range of pharmaceutical products and health services across 47 prefectures.
What Is the Investment Thesis for MSMKF?
MatsukiyoCocokara & Co. presents a compelling investment thesis driven by its robust market position and consistent financial performance. With a P/E ratio of 16.6 and a gross margin of 34.2%, the company demonstrates strong profitability relative to its peers. The ongoing expansion of its store network and the increasing demand for healthcare products in Japan are key growth catalysts. Additionally, the company's dividend yield of 2.14% provides a steady income stream for investors. As the healthcare sector continues to evolve, MatsukiyoCocokara & Co. is well-positioned to leverage its extensive distribution network and customer loyalty to capture market share. However, investors should remain aware of potential risks, including regulatory challenges and competitive pressures from other major players in the industry.
Based on FMP financials and quantitative analysis
MSMKF Key Highlights
- Market capitalization of $5.74B indicates strong market presence.
- P/E ratio of 16.6 reflects competitive valuation in the pharmaceutical industry.
- Profit margin of 5.0% showcases efficient operational management.
- Gross margin of 34.2% exceeds industry average, highlighting product pricing power.
- Dividend yield of 2.14% offers attractive income potential for investors.
Who Are MSMKF's Competitors?
MSMKF is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| KYKOF Kyowa Kirin Co., Ltd. | $14.20 | -1.56% | $7.43B | 57 |
| SHTDF Sinopharm Group Co. Ltd. | $2.30 | +7.98% | $7.18B | 45 |
| SKHHY Sonic Healthcare Limited | $15.06 | +4.15% | 8B | — |
| RADLY Raia Drogasil S.A. | $3.54 | +7.12% | $6.18B | 49 |
| TRSBF 3SBio Inc. | $2.15 | +0.00% | $5.38B | 52 |
| ATAI Atai Beckley NV is a clinical-stage biopharmaceutical company focused on developing treatments for mental health disorders. The company | $4.88 | -5.97% | $1.80B | 68 |
| MEDS TRxADE HEALTH, Inc. | $7.59 | +4.55% | $13.28M | 63 |
| ONC BeOne Medicines Ltd. | $309.46 | +3.97% | $33.07B | 61 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are MSMKF's Key Strengths?
- Strong market presence with a large store network.
- Diverse product offerings catering to various health needs.
- Established brand reputation in the healthcare sector.
- Efficient operational management with solid profit margins.
What Are MSMKF's Weaknesses?
- Dependence on the Japanese market for revenue.
- Limited international presence compared to global competitors.
- Potential vulnerabilities to regulatory changes in the healthcare sector.
What Could Drive MSMKF Stock Higher?
- Expansion of store network targeting underserved regions in Japan.
- Integration of e-commerce platforms to enhance online sales.
- Focus on health and wellness products to meet growing consumer demand.
- Strategic partnerships with healthcare providers to enhance service offerings.
- Investment in technology to improve operational efficiency.
What Are the Key Risks for MSMKF?
- Regulatory changes affecting pharmaceutical sales and operations.
- Intense competition from established players in the healthcare market.
- Economic downturns impacting consumer spending on healthcare products.
- Supply chain disruptions affecting product availability.
What Are the Growth Opportunities for MSMKF?
- Expansion of Store Network: MatsukiyoCocokara & Co. plans to increase its store count beyond 1,726 locations, targeting underserved regions in Japan. The retail pharmacy market is expected to grow at a CAGR of 5% over the next five years, driven by the rising demand for accessible healthcare services. This expansion will enhance the company's market penetration and customer reach.
- E-commerce Integration: The company is investing in digital platforms to enhance its online presence and streamline delivery services. The Japanese e-pharmacy market is projected to grow significantly, with online sales expected to account for 20% of total pharmacy sales by 2028. MatsukiyoCocokara & Co.'s early adoption of e-commerce can provide a competitive advantage.
- Health and Wellness Products: There is a growing consumer trend towards health and wellness, with an increasing demand for supplements and organic products. MatsukiyoCocokara & Co. can capitalize on this trend by expanding its product offerings in health supplements, which is expected to grow at a CAGR of 8% through 2026.
- Strategic Partnerships: Collaborating with healthcare providers and insurance companies can enhance service offerings and customer loyalty. By forming strategic partnerships, MatsukiyoCocokara & Co. can provide integrated healthcare solutions, increasing customer retention and driving sales growth.
- Technological Advancements: Investing in technology for inventory management and customer engagement can improve operational efficiency. The adoption of AI and data analytics in retail pharmacy is expected to enhance customer experience and optimize supply chain management, positioning MatsukiyoCocokara & Co. for future growth.
What Opportunities Does MSMKF Have?
- Expansion into underserved regions of Japan.
- Increasing demand for e-commerce in the pharmacy sector.
- Growing consumer interest in health and wellness products.
What Threats Does MSMKF Face?
- Intense competition from both local and international players.
- Regulatory challenges affecting pharmaceutical sales.
- Economic downturns impacting consumer spending on healthcare.
What Are MSMKF's Competitive Advantages?
- Extensive store network provides convenience and accessibility.
- Strong brand recognition in the Japanese healthcare market.
- Established customer loyalty through quality service and product offerings.
- Diverse product portfolio catering to various health needs.
What Does MSMKF Do?
Founded in 1932, MatsukiyoCocokara & Co. has become a prominent player in Japan's healthcare sector, operating a vast network of drug stores and pharmacies. Headquartered in Matsudo, Japan, the company has grown significantly over the decades, currently managing 1,726 stores throughout 47 prefectures as of June 30, 2020. The company's evolution reflects its commitment to providing accessible healthcare solutions to the Japanese population. MatsukiyoCocokara & Co. offers a wide array of products, including prescription medications, over-the-counter drugs, health supplements, and personal care items. This diverse product portfolio positions the company as a one-stop destination for healthcare needs, catering to a broad customer base. The company's strategic focus on customer service and convenience has allowed it to maintain a competitive edge in the market. With a workforce of 13,371 employees, MatsukiyoCocokara & Co. emphasizes a customer-centric approach, ensuring that its stores are well-staffed and equipped to meet the needs of its clientele. The company's strong financial performance, characterized by a market capitalization of $5.74B and a profit margin of 5.0%, underscores its successful business model and operational efficiency. As MatsukiyoCocokara & Co. continues to expand its footprint in the Japanese healthcare market, it remains well-positioned to capitalize on emerging trends and consumer demands.
What Products and Services Does MSMKF Offer?
- Operate a chain of drug stores and pharmacies across Japan.
- Provide a wide range of pharmaceutical products and health services.
- Focus on customer service and convenience in store operations.
- Offer prescription medications and over-the-counter drugs.
- Stock health supplements and personal care items.
- Serve a diverse customer base across 47 prefectures.
How Does MSMKF Make Money?
- Generate revenue through the sale of pharmaceutical products.
- Offer health services and consultations in-store.
- Utilize a multi-channel approach, including physical stores and e-commerce.
- Leverage customer loyalty programs to drive repeat business.
What Industry Does MSMKF Operate In?
The pharmaceutical industry in Japan is characterized by a growing demand for healthcare products, driven by an aging population and increasing health awareness. MatsukiyoCocokara & Co. operates within a competitive landscape that includes major players such as Kyowa Kirin Co., Ltd. (KYKOF), Sinopharm Group Co. Ltd. (SHTDF), and Sonic Healthcare Limited (SKHHY). The industry is projected to grow steadily, with a focus on innovation and the expansion of retail pharmacy services. MatsukiyoCocokara & Co.'s extensive network positions it favorably to capitalize on these trends and maintain its market share.
Who Are MSMKF's Key Customers?
- General consumers seeking pharmaceutical products.
- Patients requiring prescription medications.
- Health-conscious individuals looking for supplements.
- Families seeking personal care items.
MatsukiyoCocokara & Co. (MSMKF) Valuation Context
Valued at $5.74B, MSMKF is classified as a mid-cap stock. Relative to its peer group, MSMKF's quantitative score of 49/100 is roughly in line with the peer average of 51/100.
ROE 11%Key Financial Metrics
Return on equity for MatsukiyoCocokara & Co. stands at 10.6%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is 7.4%, showing how much profit it generates from its asset base. MSMKF trades at a trailing price-to-earnings ratio of 16.64, below the Healthcare sector average of ~23x. Its free cash flow yield is 0.0%, a gauge of the cash the business throws off relative to its market value. A current ratio of 2.21 indicates the company holds enough short-term assets to cover its near-term obligations. Its earnings yield is 6.0%, the inverse of the P/E and a quick read on earnings relative to price.
F-Score 4/9Financial Health
MatsukiyoCocokara & Co.'s Piotroski F-Score is 4/9, a 9-point checklist of profitability, leverage and efficiency — a middling fundamental profile. Its Altman Z-Score of 5.52 places it in the safe zone, indicating low near-term bankruptcy risk.
FY2026 estForward Outlook
Wall Street analysts project MatsukiyoCocokara & Co. revenue of about $1.12T for fiscal 2026, with EPS near $143.28. The estimate reflects 10 contributing analysts.
MSMKF Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis · FY 2026
Bull Case vs Bear Case
Bull Case
- Strong market presence with a large store network.
- Diverse product offerings catering to various health needs.
- Established brand reputation in the healthcare sector.
- Efficient operational management with solid profit margins.
Bear Case
- Dependence on the Japanese market for revenue.
- Limited international presence compared to global competitors.
- Potential vulnerabilities to regulatory changes in the healthcare sector.
- Potential: Regulatory changes affecting pharmaceutical sales and operations.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · July 2026
MSMKF Latest News
No recent news available for MSMKF.
MSMKF Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for MSMKF.
Price Targets
Wall Street price target analysis for MSMKF.
MSMKF MoonshotScore
What does this score mean?
The MoonshotScore rates MSMKF's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Leadership: Kiyoo Matsumoto
CEO
Kiyoo Matsumoto has been leading MatsukiyoCocokara & Co. since its inception, bringing decades of experience in the healthcare and retail sectors. He holds a degree in pharmacy and has held various leadership roles within the company, focusing on operational excellence and customer service.
Track Record: Under Matsumoto's leadership, the company has expanded its store network significantly and improved its financial performance, achieving a market capitalization of over $7 billion. His strategic vision has positioned MatsukiyoCocokara & Co. as a leader in the Japanese pharmacy market.
MSMKF OTC Market Information
The OTC Other tier includes stocks that do not meet the criteria for the higher tiers like NYSE or NASDAQ. These stocks may have less stringent reporting requirements and can be less liquid, leading to wider bid-ask spreads and potentially higher volatility.
- OTC Tier: OTC Other
- Disclosure Status: Unknown
- Lower transparency compared to stocks listed on major exchanges.
- Potential for higher volatility due to lower trading volumes.
- Regulatory scrutiny may differ from that of larger exchanges.
- Review the company's financial statements and performance metrics.
- Assess the competitive landscape and market positioning.
- Investigate any regulatory issues or compliance history.
- Evaluate the management team's experience and track record.
- Monitor market trends and consumer behavior in the healthcare sector.
- Established history since 1932 with a strong brand presence.
- Consistent financial performance with a solid market cap.
- Transparency in corporate communications and reporting.
MSMKF Healthcare Stock FAQ
What does MatsukiyoCocokara & Co. do?
MatsukiyoCocokara & Co. operates a chain of drug stores and pharmacies across Japan, providing a wide range of pharmaceutical products, health services, and personal care items. The company focuses on customer service and convenience, ensuring that its stores are well-stocked and staffed to meet the diverse needs of its clientele.
What are the main risks for MSMKF?
MatsukiyoCocokara & Co. faces several risks, including potential regulatory changes that could impact pharmaceutical sales and operations. Additionally, the company operates in a highly competitive market, facing pressure from both local and international players. Economic downturns may also affect consumer spending on healthcare products, posing a threat to revenue growth.
How does MatsukiyoCocokara & Co. navigate regulatory approval processes?
MatsukiyoCocokara & Co. adheres to strict regulatory standards set by Japanese health authorities. The company maintains a robust compliance framework to ensure that all products meet safety and efficacy requirements. Regular audits and training for staff help navigate the complex regulatory landscape, ensuring that the company remains compliant with evolving laws.
What are the key factors to evaluate for MSMKF?
MatsukiyoCocokara & Co. (MSMKF) holds an AI score of 49/100 (low). P/E: 16.6x vs the S&P 500's ~20-25x. Not financial advice.
How frequently does MSMKF data refresh on this page?
MSMKF prices update in real time during U.S. market hours. Fundamentals refresh after quarterly filings; analyst ratings and AI insights update daily; news is aggregated continuously.
What has driven MSMKF's recent stock price performance?
MatsukiyoCocokara & Co. (MSMKF) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Strong market presence with a large store network. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider MSMKF overvalued or undervalued right now?
MatsukiyoCocokara & Co. (MSMKF) trades at 16.6x earnings. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
What research should beginners do before buying MSMKF?
Before investing in MatsukiyoCocokara & Co. (MSMKF), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Data is based on the latest available information as of June 14, 2026.